Alkem Labs Q3 Results: Profit and margin expand from last year; dividend announced

Alkem Labs Q3 Results: For the first nine months of FY25, EBITDA margin stood at 21.6% as against FY25 guidance of 18.5-19%.

Leave a Reply

Your email address will not be published. Required fields are marked *